David Lee, Servier US CEO (Servier)
Once aiming to double oncology pipeline, Servier's US branch touts rapid pace in building its foothold in the space
The US subsidiary of French pharma Servier has only been in existence for a touch under three years, but it hasn’t wasted a second …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
